Publication:
Molecular insights into fosfomycin resistance in Escherichia coli.

dc.contributor.authorBallestero-Tellez, M
dc.contributor.authorDocobo-Perez, F
dc.contributor.authorPortillo-Calderon, I
dc.contributor.authorRodriguez-Martinez, J M
dc.contributor.authorRacero, L
dc.contributor.authorRamos-Guelfo, M S
dc.contributor.authorBlazquez, J
dc.contributor.authorRodriguez-Baño, J
dc.contributor.authorPascual, A
dc.contributor.funderMinisterio de Economía y Competitividad, Instituto de Salud Carlos III
dc.contributor.funderConsejería de Igualdad, Salud y Políticas Sociales, Junta de Andalucía
dc.date.accessioned2023-01-25T09:43:02Z
dc.date.available2023-01-25T09:43:02Z
dc.date.issued2017
dc.description.abstractFosfomycin activity in Escherichia coli depends on several genes of unknown importance for fosfomycin resistance. The objective was to characterize the role of uhpT, glpT, cyaA and ptsI genes in fosfomycin resistance in E. coli. Methods : WT E. coli BW25113 and null mutants, ΔuhpT, ΔglpT, ΔcyaA, ΔptsI, ΔglpT-uhpT, ΔglpT-cyaA, ΔglpT-ptsI, ΔuhpT-cyaA, ΔuhpT-ptsI and ΔptsI-cyaA, were studied. Susceptibility to fosfomycin was tested using CLSI guidelines. Fosfomycin mutant frequencies were determined at concentrations of 64 and 256 mg/L. Fosfomycin in vitro activity was tested using time –kill assays at concentrations of 64 and 307 mg/L ( human Cmax).Results: Fosfomycin MICs were: WT E. coli BW25113 (2 mg/L), ΔglpT (2 mg/L), ΔuhpT (64 mg/L), ΔcyaA (8 mg/L), ΔptsI (2 mg/L), ΔglpT-uhpT (256 mg/L), ΔglpT-cyaA (8 mg/L), ΔglpT-ptsI (2 mg/L), ΔuhpT-cyaA (512 mg/L), ΔuhpT-ptsI (64 mg/L) and ΔptsI-cyaA (32 mg/L). In the mutant frequency assays, no mutants were recovered from BW25113. Mutants appeared in ΔglpT, ΔuhpT, ΔcyaA and ΔptsI at 64 mg/L and in ΔuhpT and ΔcyaA at 256 mg/L. ΔglpT-ptsI, but not ΔglpT-cyaA, ΔuhpT-cyaA or ΔuhpT-ptsI, increased the mutant frequency compared with the highest frequency found in each single mutant. In time –kill assays, all mutants regrew at 64 mg/L. Initial bacterial reductions of 2–4 log10 cfu/mL were observed for all strains , except for ΔuhpT-ptsI, ΔglpT-uhpT and ΔuhpT-cyaA. Only ΔglpT and ΔptsI mutants were cleared using 307 mg/L.Conclusions: Fosfomycin MIC may not be a good efficacy predictor, as highly resistant mutants may appear, depending on other pre-existing mutations with no impact on MIC.
dc.description.versionSi
dc.identifier.citationBallestero-Téllez M, Docobo-Pérez F, Portillo-Calderón I, Rodríguez-Martínez JM, Racero L, Ramos-Guelfo MS, et al. Molecular insights into fosfomycin resistance in Escherichia coli. J Antimicrob Chemother. 2017 May 1;72(5):1303-1309.
dc.identifier.doi10.1093/jac/dkw573
dc.identifier.essn1460-2091
dc.identifier.pmid28093485
dc.identifier.unpaywallURLhttps://academic.oup.com/jac/article-pdf/72/5/1303/13703426/dkw573.pdf
dc.identifier.urihttp://hdl.handle.net/10668/10781
dc.issue.number5
dc.journal.titleThe Journal of antimicrobial chemotherapy
dc.journal.titleabbreviationJ Antimicrob Chemother
dc.language.isoen
dc.organizationInstituto de Biomedicina de Sevilla-IBIS
dc.organizationHospital Universitario Virgen del Rocío
dc.organizationHospital Universitario Virgen Macarena
dc.page.number1303-1309
dc.provenanceRealizada la curación de contenido 16/06/2025.
dc.publisherOxford University Press
dc.pubmedtypeJournal Article
dc.relation.projectIDPI13/01885
dc.relation.projectIDPI 13/01282
dc.relation.projectIDPI-0044-2013
dc.relation.publisherversionhttps://academic.oup.com/jac/article-lookup/doi/10.1093/jac/dkw573
dc.rights.accessRightsRestricted Access
dc.subjectAnti-Bacterial Agents
dc.subjectDrug Resistance, Bacterial
dc.subjectGenes, MDR
dc.subjectMicrobial Sensitivity Tests
dc.subject.decsFosfomicina
dc.subject.decsHumanos
dc.subject.decsTécnicas In Vitro
dc.subject.decsMutación
dc.subject.decsEscherichia coli
dc.subject.decsEficacia
dc.subject.meshDNA, Bacterial
dc.subject.meshEscherichia coli
dc.subject.meshEscherichia coli Proteins
dc.subject.meshFosfomycin
dc.subject.meshHumans
dc.subject.meshMutation
dc.titleMolecular insights into fosfomycin resistance in Escherichia coli.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number72
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
RISalud_Accesorestringido.pdf
Size:
93.39 KB
Format:
Adobe Portable Document Format